Title: From the Editor’s Desk
Authors: PJ Commerford
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 127
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
Abstract: This issue carries several
important messages for those interested in
cardiovascular heath in Africa. In the landmark
Addis Ababa communiqué, Watkins and colleagues
(page 184) describe seven essential actions
aimed at eliminating rheumatic heart disease
(RHD) in Africa. The distinguished group of
authors are widely representative of Africans
knowledgeable and active in both research and
clinical service in this field and they are
supported by international experts. Most
importantly, this third All-Africa Workshop on
Acute Rheumatic Fever and Rheumatic Heart
Disease was hosted by the social cluster of the
African Union Commission, and the communiqué has
since been endorsed by African Union heads of
state. Therefore the political will and support
so necessary for successful implementation seems
to be available and will be essential in the
years ahead. The communiqué identifies that one
of the barriers to eradicating RHD in Africa is
that there are few centres capable of providing
cardiac surgery, and action five aims to
‘Establish centres of excellence for cardiac
surgery, which will sustainably deliver
state-of-the-art surgical care, train the next
generation of African cardiac practitioners, and
conduct research on endemic cardiovascular
diseases, including RHD’..
Title: Iloprost as an acute kidney
injury-triggering agent in severely
atherosclerotic patients
Authors: ME Uyar, P Yucel, S Ilin, Z Bal, S
Yildirim, AS Uyar, T Akay, E Tutal, S Sezer
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 128-133
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number:10.5830/CVJA-2015-051
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-051
Background: Iloprost, a stable prostacyclin
analog, is used as a rescue therapy for severe
peripheral arterial disease (PAD). It has
systemic vasodilatory and anti-aggregant
effects, with severe vasodilatation potentially
causing organ ischaemia when severe
atherosclerosis is the underlying cause. In this
study, we retrospectively analysed renal
outcomes after iloprost infusion therapy in 86
patients.
Methods: Eighty-six patients with PAD who
received iloprost infusion therapy were
retrospectively analysed. Clinical and
biochemical parameters were recorded before
(initial, Cr1), during (third day, Cr2), and
after (14th day following the termination of
infusion therapy, Cr3) treatment. Acute kidney
injury (AKI) was defined according to KDIGO
guidelines as a ≥ 0.3 mg/dl (26.52 μmol/l)
increase in creatinine levels from baseline
within 48 hours.
Results: Cr2 (1.46 ± 0.1 mg/dl) (129.06 ± 8.84
μmol/l) and Cr3 (1.53 ± 0.12 mg/dl) (135.25 ±
10.61 μmol/l) creatinine levels were
significantly higher compared to the initial
value (1.15 ± 0.6 mg/dl) (101.66 ± 53.04
μmol/l). AKI was observed in 36 patients
(41.86%) on the third day of iloprost infusion.
Logistic regression analysis revealed smoking
and not using acetylsalicylic acid as primary
predictors (p = 0.02 and p = 0.008,
respectively) of AKI during iloprost treatment.
On the third infusion day, patients’ urinary
output significantly increased (1813.30 ±
1123.46 vs 1545.17 ± 873.00 cm<sup>3</sup>) and
diastolic blood pressure significantly decreased
(70.07 ± 15.50 vs 74.14 ± 9.42 mmHg) from their
initial values.
Conclusion: While iloprost treatment is
effective in patients with PAD who are not
suitable for surgery, severe systemic
vasodilatation can cause renal ischaemia,
resulting in nonoliguric AKI. Smoking, no
acetylsalicylic acid use, and lower diastolic
blood pressure are the clinical risk factors for
AKI during iloprost treatment.
Title: Changes in cardiac structure and function in a modified rat
model of myocardial hypertrophy
Authors: W Dai, Q Dong, M Chen, L Zhao, A Chen,
Z Li, S Liu
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 134-142
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number:10.5830/CVJA-2015-053
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-053
Aim: In this study we designed a modified method
of abdominal aortic constriction (AAC) in order to establish a stable animal
model of left ventricular hypertrophy (LVH). We also evaluated cardiac structure
and function in rats with myocardial hypertrophy using echocardiography, and
provide a theory and experimental basis for the application of drug
interventions using the LVH animal model. We hope this model will provide
insight into novel clinical therapies for LVH.
Methods: The abdominal aorta of male Wistar rats (80–100 g) was constricted
between the branches of the coeliac and anterior mesenteric arteries, to a
diameter of 0.55 mm. Echocardiography, using a linear phase array probe,
combined with histology and plasma BNP concentration, was performed at three,
four and six weeks post AAC.
Results: The acute (24-hour) mortality rate was lower (8%) than in previous
reports (15%) using this modified rat model. Compared with shams, animals who
underwent AAC demonstrated significantly increased interventricular septal
(IVS), LV posterior wall (LVPWd), LV mass index (LVMI), crosssectional area
(CSA) of myocytes, and perivascular fibrosis; while the ejection fraction (EF),
fractional shortening (FS) and cardiac output (CO) were consistently lower at
each time interval. Notably, differences in these parameters between the AAC and
sham groups were significant by three weeks and reached a peak at four weeks.
Following AAC, plasma B-type natriuretic peptide (BNP) level was gradually
elevated, compared with the sham group, between three and six weeks.
Conclusion: This modified AAC model induced LVH both stably and safely by week
four post surgery. Echocardiography was accurately able to assess changes in
chamber dimensions and systolic properties in the rats with LVH.
Title: Subclavian artery cannulation
provides better myocardial protection in
conventional repair of acute type A aortic
dissection: experience from a single medical
centre in Taiwan
Authors: P-S Hsu, J-L Chen, C-S Tsai, Y-T Tsai,
C-Y Lin, C-Y Lee, H-Y Ke, Y-C Lin
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 143-146
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-056
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-056
Background: Although many reports have detailed
the advantages and disadvantages between femoral
and subclavian arterial cannulations for acute
aortic dissection type A (AADA), the confounding
factors caused by disease severity and surgical
procedures could not be completely eliminated.
We compared femoral and subclavian artery
cannulation and report the results for
reconstruction of only the ascending aorta.
Methods: From January 2003 to December 2010, 51
AADA cases involving reconstruction of only the
ascending aorta were retrospectively reviewed
and categorised on the basis of femoral (n = 26,
51%) or subclavian (n = 25, 49%) artery
cannulation. Bentall’s procedures, arch
reconstruction and hybrid operations with
stent-grafts were all excluded to avoid
confounding factors due to dissection severity.
Surgical results, postoperative mortality, and
short- and mid-term outcomes were compared
between the groups.
Results: Subclavian cannulation had a lower
incidence of cerebral and myocardial injury and
lower hospital mortality than femoral
cannulation (8 vs 34%, p = 0.04). Ventilation
duration as well as intensive care unit (ICU)
and hospital stay were also shorter with
subclavian cannulation. Risk factors for
hospital mortality included pre-operative
respiratory failure (odds ratio: 12.84),
peri-operative cardiopulmonary bypass (CPB) time
> 200 minutes (odds ratio: 13.49), postoperative
acidosis (pH < 7.2, odds ratio: 88.63), and
troponin I > 2.0 ng/ml (odds ratio: 20.08). The
overall hospital mortality rate was 21%. The 40
survivors were followed up for three years with
survival of 75% at one year and 70% at three
years.
Conclusions: Our results show that subclavian
cannulation had a lower incidence of cerebral
and myocardial injury as well as better
postoperative recovery and lower hospital
mortality rates for reconstruction of only the
ascending aorta.
Title: Comparison of two different techniques for balloon sizing in
percutaneous mitral balloon valvuloplasty: which is preferable?
Authors: A Tastan, A Ozturk, O Senarslan, E
Ozel, S Uyar, EE Ozcan, O Kozan
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages:
147-151
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-062
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-062
Background: Percutaneous balloon mitral
valvuloplasty (BMV) is an important option for the treatment of mitral valve
stenosis. The crux of this process is choosing the appropriate Inoue balloon
size. There are two methods to do this. One is an empirical formula based on the
patient’s height, and other is to choose according to the maximal
inter-commissural distance of the mitral valve provided by echocardiography.
Methods: The study, performed between January 2006 and December 2011, included
128 patients who had moderate to severe mitral stenosis and whose valve
morphology was suitable for BMV. Patients were randomised into two groups. One
group was allocated to conventional height-based balloon reference sizing (the
HBRS group) and the other was allocated to balloons sized by the
echocardiographic measurement of the diastolic inter-commissural diameter (the
EBRS group).
Results: BMV was assessed as successful in 60 (92.3%) patients in the HBRS group
and in 61 (96.8%) in the EBRS group (p = 0.03). The mean of the calculated
balloon reference sizes was significantly higher in the HBRS than in the EBRS
group [26.3 ± 1.2 mm, 95% confidence interval (CI): 26.1–26.6 vs 25.2 ± 1.1, 95%
CI: 25.0–25.4, respectively; p = 0.007). Final mitral valve areas (MVA) were
larger and mitral regurgitation (MR) > 2+ was less in the EBRS group (p = 0.02
and p = 0.05, respectively).
Conclusions: EBRS is a method that is independent of body structure. Choosing
Inoue balloon size by measuring maximal diastolic annulus diameter by
echocardiography for BMV may be an acceptable method for appropriate final MVA
and to avoid risk of significant MR.
Title: Clinical features, spectrum
of causal genetic mutations and outcome of
hypertrophic cardiomyopathy in South Africans
Authors: NAB Ntusi, G Shaboodien, M Badri, F
Gumedze, BM Mayosi
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 152-158
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-075
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-075
Background: Little is known about the clinical
characteristics, spectrum of causal genetic
mutations and outcome of hypertrophic
cardiomyopathy (HCM) in Africans. The objective
of this study was to delineate the clinical and
genetic features and outcome of HCM in African
patients.
Methods: Information on clinical presentation,
electrocardiographic and echocardiographic
findings, and outcome of cases with HCM was
collected from the Cardiac Clinic at Groote
Schuur Hospital over a mean duration of follow
up of 9.1 ± 3.4 years. Genomic DNA was screened
for mutations in 15 genes that cause HCM, i.e.
cardiac myosinbinding protein C (MYBPC3),
cardiac β-myosin heavy chain (MYH7), cardiac
troponin T2 (TNNT2), cardiac troponin I (TNNI3),
regulatory light chain of myosin (MYL2),
essential light chain of myosin (MYL3),
tropomyosin 1 (TPM1), phospholamban (PLN),
α-actin (ACTC1), cysteine and glycine-rich
protein 3 (CSRP3), AMP-activated protein kinase
(PRKAG2), α-galactosidase (GLA), four-and-a-half
LIM domains 1 (FHL1), lamin A/C (LMNA) and
lysosomeassociated membrane protein 2 (LAMP2).
Survival and its predictors were analysed using
the Kaplan–Meier and Cox proportional hazards
regression methods, respectively.
Results: Forty-three consecutive patients [mean
age 38.5 ± 14.3 years; 25 (58.1%) male; and 13
(30.2%) black African] were prospectively
enrolled in the study from January 1996 to
December 2012. Clinical presentation was similar
to that reported in other studies. The South
African founder mutations that cause HCM were
not found in the 42 probands. Ten of 35 index
cases (28.6%) tested for mutations in 15 genes
had disease-causing mutations in MYH7 (six cases
or 60%) and MYBPC3 (four cases or 40%). No
disease-causing mutation was found in the other
13 genes screened. The annual mortality rate was
2.9% per annum and overall survival was 74% at
10 years, which was similar to the general South
African population. Cox’s proportional hazards
regression showed that survival was predicted by
New York Heart Association (NYHA) functional
class at last visit (p = 0.026), but not by the
presence of a disease-causing mutation (p =
0.474).
Conclusions: Comprehensive genetic screening was
associated with a 29% yield of causal genetic
mutations in South African HCM cases, all in
MYH7 and MBPC3 genes. A quarter of the patients
had died after a decade of follow up, with NYHA
functional class serving as a predictor of
survival.
Title: Administration of perivascular cyanoacrylate for the
prevention of cellular damage in saphenous vein grafts: an experimental model
Authors: N Kahraman, G Yumun, A Gücü, KK Özsin,
T Taner, E Şener,
MT Göncü
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 159-163
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-078
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-078
Objective: The saphenous vein is the most
commonly used graft in coronary artery bypass surgery, since no suitable
arterial graft is available. However, the frequency of late graft failure is a
cause for research into graft protection. The objective of this study was to
investigate the effect of synthetic adhesive cyanoacrylate administration on the
saphenous vein graft for preventing vascular damage due to internal pressure on
the graft.
Methods: In this study we enrolled 20 volunteer subjects who had undergone
coronary artery bypass surgery and who had excess saphenous vein grafts.
Perivascular cyanoacrylate was administered to one of two saphenous vein grafts
explanted from each patient. The other saphenous vein graft from each patient
was not treated and was used as the control. A model of the arterial system was
created using a saphenous vein cardiopulmonary bypass system. Circulation was
maintained at 120 mmHg for 45 minutes. Afterwards, the grafts were subjected to
histopathological examination.
Results: The cyanoacrylate group of grafts did not develop severe vascular
damage compared with many instances of moderate and severe damage due to
compression in the control group of grafts (p = 0.003).
Conclusion: Perivascular administration of cyanoacrylate appeared to be
successful in the prevention of early saphenous vein graft injury. No in vivo
study has been performed to date to assess endothelial damage in the saphenous
vein, in order to demonstrate the long-term effect of cyanoacrylate. Further
investigations are needed in this regard.
Title: Effects of a PPAR -gamma receptor agonist and an angiotensin
receptor antagonist on aortic contractile responses to alpha receptor agonists
in diabetic and/or hypertensive rats
Authors: I Tugrul, T Dost, O Demir, F Gokalp, O
Oz, N Girit, M Birincioglu
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 164-169
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-080
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-080
Aim: The aim of this study was to investigate
the effects of pioglitazone and losartan pre-treatment on the aortic contractile
response to the alpha-1 agonist, phenylephrine, and the alpha-2 agonist,
clonidine, in L-NAME-induced hypertensive, STZ-induced diabetic, and
hypertensive diabetic rats.
Methods: Male Wistar rats were randomly allocated to four groups: control,
diabetic (DM), hypertensive (HT) and hypertensive diabetic (HT + DM) groups.
Three weeks after drug application, in vitro dose–response curves to
phenylephrine (Phe) (10-9–10-5 M) and clonidine (Clo) (10-9–10-5 M) were
recorded in aortic rings in the absence (control) and presence of pioglitazone
(10 μM) and/or losartan (10 μM).
Results: Pioglitazone and losartan caused a shift to the right in contractile
response to phenylephrine in all groups. The sensitivity of the aortic rings to
phenylephrine was decreased in the presence of pioglitazone and/or losartan in
all groups. The contractile response of clonidine decreased in the presence of
pioglitazone and/or losartan in the control, HT and DM groups.
Conclusion: The sensitivity of aortic rings to alpha-1 and alpha-2 adrenoceptors
was decreased in the presence of pioglitazone and/or losartan in diabetic and
hypertensive rats. Concomitant use of PPAR-gamma agonists, thiazolidinediones,
and angiotensin receptor blockers may be effective treatment for diabetes and
hypertension.
Title: Tabula viva chirurgi: a living surgical document Authors: MJ Swart, G Joubert, J-A van
den Berg, GJ van Zyl
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 170-176
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-081
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-081
Aim: The purpose of this article is to present
the results of a private cardiac surgical practice. This information could also
serve as a hermeneutical text for new wisdom.
Methods: A personal database of 1 750 consecutive patients who had had coronary
artery bypass graft (CABG) surgery was statistically analysed. Mortality and
major morbidity figures were compared with large registries. Risk factors for
postoperative death were determined.
Results: Over a period of 12 years, 1 344 (76.8%) males and 406 (23.2%) females
were operated on. The observed mortality rate was 3.03% and the expected
mortality rate (EuroSCORE) was 3.87%. After stepwise logistic regression,
independent risk factors for death were urgency (intra-aortic balloon pump),
renal impairment (chronic kidney disease, stage III), re-operation and an
additional procedure. Apart from the 53 deaths, another 91 patients had major
complications.
Conclusion: Mortality and morbidity rates compared favourably with other
international registries. Mortality was related to co-morbidities. This outcome
contributes to a hermeneutical understanding focusing on new spiritual wisdom
and meaning for the surgeon.
Title: Associations between body fat
distribution, insulin resistance and
dyslipidaemia in black and white South African
women Authors: D Keswell, M Tootla, JH
Goedecke
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 177-183
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-088
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-088
Aim: The aim was to examine differences in body
fat distribution between premenopausal black and
white South African (SA) women and explore the
ethnic-specific associations with
cardiometabolic risk.
Methods: Body composition, using dual-energy
X-ray absorptiometry (DXA) and computerised
tomography, insulin resistance (HOMA-IR) and
lipid levels were assessed in 288 black and 197
white premenopausal SA women.
Results: Compared to the white women, black
women had less central and more peripheral
(lower-body) fat, and lower serum lipid and
glucose concentrations, but similar homeostasis
models for insulin resistance (HOMA-IR) values.
The associations between body fat distribution
and HOMA-IR, triglyceride and high-density
lipoprotein cholesterol concentrations were
similar, while the associations with fasting
glucose, total and low-density lipoprotein
cholesterol levels differed between black and
white women.
Conclusion: Ethnic differences in body fat
distribution are associated, in part, with
differences in cardiometabolic risk between
black and white SA women.
Title: Seven key actions to eradicate rheumatic heart disease in
Africa: the Addis Ababa communiqué Authors: D Watkins, L Zuhlke, M Engel, R Daniels, V Francis, G
Shaboodien, M Kango, A Abul-Fadl, A Adeoye, S Ali, M Al-Kebsi, F Bode-Thomas, G
Bukhman, A Damasceno, DY Goshu, A Elghamrawy, B Gitura, A Haileamlak, A Hailu, C
Hugo-Hamman, S Justus, G Karthikeyan, N Kennedy, P Lwabi, Y Mamo, P Mntla, C
Sutton, AO Mocumbi, C Mondo, A Mtaja, J Musuku, J Mucumbitsi, L Murango, G Nel,
S Ogendo, E Ogola, D Ojji, TO Olunuga, MM Redi, KE Rusingiza, M Sani, S Sheta, S
Shongwe, J van Dam, H Gamra, J Carapetis, D Lennon, BM Mayosi
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 184-187
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-090
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-090
Abstract: Acute rheumatic fever (ARF) and
rheumatic heart disease (RHD) remain major causes of heart failure, stroke and
death among African women and children, despite being preventable and imminently
treatable. From 21 to 22 February 2015, the Social Cluster of the Africa Union
Commission (AUC) hosted a consultation with RHD experts convened by the
Pan-African Society of Cardiology (PASCAR) in Addis Ababa, Ethiopia, to develop
a ‘roadmap’ of key actions that need to be taken by governments to eliminate ARF
and eradicate RHD in Africa.
Seven priority areas for action were adopted: (1) create prospective disease
registers at sentinel sites in affected countries to measure disease burden and
track progress towards the reduction of mortality by 25% by the year 2025, (2)
ensure an adequate supply of high-quality benzathine penicillin for the primary
and secondary prevention of ARF/RHD, (3) improve access to reproductive health
services for women with RHD and other non-communicable diseases (NCD), (4)
decentralise technical expertise and technology for diagnosing and managing ARF
and RHD (including ultrasound of the heart), (5) establish national and regional
centres of excellence for essential cardiac surgery for the treatment of
affected patients and training of cardiovascular practitioners of the future,
(6) initiate national multi-sectoral RHD programmes within NCD control
programmes of affected countries, and (7) foster international partnerships with
multinational organsations for resource mobilisation, monitoring and evaluation
of the programme to end RHD in Africa.
This Addis Ababa communiqué has since been endorsed by African Union heads of
state, and plans are underway to implement the roadmap in order to end ARF and
RHD in Africa in our lifetime.
Title: Cardiology–cardiothoracic subspeciality training in South
Africa: a position paper of the South Africa Heart Association
Authors: K Sliwa, L Zühlke, R Kleinloog, A
Doubell, I Ebrahim, M Essop, D Kettles, D Jankelow, S Khan, E Klug, S Lecour, D
Marais, M Mpe, M Ntsekhe, L Osrin, F Smit, A Snyders, JP Theron, A Thornton, A
Chin, N van der Merwe, E Dau, A Sarkin
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 188-193
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-063
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-063
Abstract: Over the past decades, South
Africa has undergone rapid demographic changes, which have led to marked
increases in specific cardiac disease categories, such as rheumatic heart
disease (now predominantly presenting in young adults with advanced and
symptomatic disease) and coronary artery disease (with rapidly increasing
prevalence in middle age). The lack of screening facilities, delayed diagnosis
and inadequate care at primary, secondary and tertiary levels have led to a
large burden of patients with heart failure. This leads to suffering of the
patients and substantial costs to society and the healthcare system.
In this position paper, the South African Heart Association (SA Heart) National
Council members have summarised the current state of cardiology, cardiothoracic
surgery and paediatric cardiology reigning in South Africa. Our report
demonstrates that there has been minimal change in the number of successfully
qualified specialists over the last decade and, therefore, a de facto decline
per capita. We summarise the major gaps in training and possible interventions
to transform the healthcare system, dealing with the colliding epidemic of
communicable disease and the rapidly expanding epidemic of non-communicable
disease, including cardiac disease.
Title: Patterns of international collaboration in cardiovascular
research in sub-Saharan Africa
Authors: R Ettarh
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 194-200
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-082
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-082
Abstract: The rising prevalence of
cardiovascular disease in sub-Saharan Africa (SSA) constitutes a significant
health and socio-economic challenge for the countries in the region. This study
examines the patterns and scientific impact of international collaboration in
cardiovascular research (CVR) in SSA. Bibliographic data from 2005 to 2014 were
obtained from the Web of Science for cardiovascular-related publications with at
least one author affiliated to an SSA country. The number of publications
involving multiple SSA countries over this period accounted for less than 10% of
the total number of multicountry publications that included at least one SSA
country. Collaboration patterns reflected dominance by countries in Europe and
North America, with South Africa accounting for the bulk of scientific
collaboration in CVR within SSA. The findings indicate that pro-active
strategies are needed to strengthen collaboration in CVR across SSA for the
region to derive health and socio-economic benefits from locally conducted
research.
Title: Development of the roadmap for reducing cardiovascular
morbidity and mortality through the detection, treatment and control of
hypertension in Africa: report of a working group of the PAS CAR Hypertension
Task Force
Authors: A Dzudie, A Kane, E Kramoh, J-B
Anzouan-Kacou, JM Damourou, L Allawaye, J Nzisabira, L Mousse, D Balde, O
Nouhom, JL Nkoa, K Kaki, A Djomou, A Menanga, CN Nganou, JB Mipinda, L Nebie, LM
Kuate, S Kingue, SA Ba, on behalf of the PASCAR task force on hypertension
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: 200-202
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
Abstract: The fourth Pan-African Society of
Cardiology (PASCAR) hypertension taskforce meeting was held at the Yaoundé
Hilton Hotel on 16 March 2016. Its main goals were to update and facilitate
understanding of the PASCAR roadmap for the control of hypertension on the
continent, to refine the PASCAR hypertension algorithm, and to discuss the next
steps of the PASCAR hypertension policy, including how the PASCAR initiative can
be customised at country level. The formation of the PASCAR coalition against
hypertension, the writing group and the current status of the PASCAR
hypertension policy document as well as the algorithm were presented to
delegates representing 12 French-speaking countries. The urgency to finalise the
continental policy was recognised and consensus was achieved by discussion on
the main points and strategy. Relevant scientific issues were discussed and
comments were received on all points, including how the algorithm could be
simplified and made more accessible for implementation at primary healthcare
centres.
Title: Transoesophageal echocardiography (TEE) at the Institute of
Cardiology in Abidjan: indications, results and diagnostic accuracy
Authors: J-B Anzouan-Kacou, C Konin, C-P Zobo, D
Bamba-Kamagaté, M-P N’cho-Mottoh, B Boka
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: e1-e4
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2015-054
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2015-054
Objective: The aim of the study was to define
the indications for and results and diagnostic accuracy of transoesophageal
echocardiography (TEE) in the Abidjan Cardiology Institute.
Methods: A retrospective analysis was carried out of 103 TEE reports from
February 2007 to January 2011. The analysis focused on the clinical
characteristics of the patients, quality of the prescribers, and indications and
diagnostic accuracy (proportion of confirmed diagnoses, which is the ratio of
‘anomaly found/number of examinations made for the indication’).
Results: There were 47 women (45.6%) and 56 men (54. 4%) in the study, with an
average age of 37.9 ± 16.4 years. Prescribers were mostly cardiologists (n = 57;
55.4%). The indications were predominantly evaluation for atrial septal defect
(ASD, 34.9%), investigation for thrombus due to rhythm disturbance before
cardioversion (18.4%), aetiological evaluation of ischaemic stroke (13.5%), and
assessment for mitral regurgitation (lesion assessment, mechanism and/or
quantification, 9.7%). In the evaluation for an ASD, TEE was contributory in
17.3% and for thrombus, it was 21%. No embolic aetiology was found in the
ischaemic strokes. Three examinations were done during cardiac surgery to assess
the mechanical valves or quality of mitral plasty. There were no incidents or
accidents reported during those 103 examinations.
Conclusion: Because of the high number of congenital heart disease cases
discovered in adulthood involving arrhythmias and valvular heart disease, TEE is
likely to become more important as a means of diagnosis, and should be used
correctly so as to achieve optimal diagnostic advantage. TEE should be provided
by specialists not cardiologists.
Title: A case of enoxaparin-induced thrombocytopaenia during
treatment of acute myocardial infarction
Authors: SY Lim, SR Lee, YH Kim, JS Kim, SH Kim,
JC Ahn, WH Song
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: e5-e8
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-010
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-010
Abstract: Heparin-induced thrombocytopaenia is a
life-threatening complication, affecting the morbidity and mortality of the
patient if not properly treated. We report a case of a 75-year-old female
patient who experienced enoxaparininduced thrombocytopaenia during medical
treatment of acute ST-segment elevation myocardial infarction due to thrombotic
total occlusion in the large right coronary artery.
Title: Transcatheter intervention in a child with scimitar syndrome
Authors: Z Wang, X Cai
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: e9-e11
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-004
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-004
Abstract: Scimitar syndrome is a rare congenital
heart disease characterised by anomalous pulmonary venous drainage to the
inferior vena cava, aortopulmonary collaterals, hypoplasia of the right lung and
intracardiac defects. Surgical correction remains the gold-standard therapy.
However, non-surgical intervention has been reported effective in selected cases
with scimitar syndrome. We report on a one-year-old boy with scimitar syndrome
who underwent stepwise transcatheter intervention as an alternative treatment.
Embolisation of the aortopulmonary collaterals and occlusion of the atrial
septal defect were performed using detachable coils and an Amplatzer septal
occluder, respectively. The patient’s postcathetherisation course was
uneventful. The right cardiac chamber and pulmonary arterial pressure returned
to normal during follow up.
Title: Short-term warfarin treatment for apical thrombus in a
patient with Takotsubo cardiomyopathy
Authors: A İcli, H Akilli, M Kayrak, A Aribas, K
Ozdemir
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: e12-e14
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-011
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-011
Abstract: Takotsubo cardiomyopathy (TCMP) is
characterised by a temporary aneurysm of the left ventricular apex in
individuals without significant stenosis of the coronary arteries. It is
extremely rare to see it combined with a thrombus. In this case report, we
present a 57-year-old female patient with TCMP in whom apical thrombus was
treated with short-term warfarin use.
Title: Unexpected complication of oesophagoscopy: iatrogenic aortic
injury in a child
Authors: O Tezcan, M Oruc, M Kuyumcu, S
Demirtas, C Yavuz, O Karahan
From: Cardiovascular Journal of Africa, Vol 27,
Issue 3, May/June
Published: 2016
Pages: e15-e17
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-015
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-015
Introduction: Oesophagoscopy is usually a safe
procedure to localise and remove ingested foreign bodies, however, unexpected
complications may develop during this procedure. In this case report we discuss
iatrogenic aortic injury, which developed during oesophagoscopy, and its
immediate treatment.
Case report: A six-year-old male patient was admitted to hospital with symptoms
of having ingested a foreign body. Oesophagoscopy was carried out and the
foreign body was visualised at the second constriction of the oesophagus. During
this procedure, profuse bleeding occurred. Subsequently, a balloon dilator was
placed to control bleeding in the oesophagus. Thoracic contrast tomography
revealed thoracic aortic injury. Open surgical aortic repair was immediately
carried out on the patient and the oesophageal hole was primarily repaired. The
patient was discharged on postoperative day 15 with a total cure.
Conclusion: Although oesophagoscopy is a safe, easily applied method, it should
be kept in mind that fatal complications may occur during the procedure. This
procedure should be done in high-level medical centres, which have extra
facilities for managing complications.